Resources Top 5: Mont Royal makes strong return to the boards after landing Canadian rare earths play
Health Check: Our flu recovery prognosis is positive, CSL tells investors
Top cyber scientist warns of quantum computing security threats
Biocurious: Buoyed by capital raisings, biotechs storm home with a wet sail
Lunch Wrap: Rare earths tumble and tech rattled as the Big Short returns
Silver tsunami wave captures 700,000 retirees in super tax trap
ASX Tech October Winners: Sector buckles under Xero and WiseTech, but Weebit joins $1bn club
Break it Down: Tryptamine raises $6.1m to fast-track world-first binge eating disorder trial
ASX Health October Winners: When CSL sneezes, sector catches flu
ASX Health Quarterly Wrap: Progress on multiple fronts in strong start to FY26
Contributors
Our Resident Experts
Mining
Resources Top 5: Investors look to back a winning horse as Richardson Street Group gets De Grey band back together
Up, Up, Down, Down: Gold hit a record but will we look back on October as lithium’s turning point?
Resources Top 5: Investors rush to board the Mount Ridley gallium train
Big Tech’s nuclear pivot: How Amazon, Google and Meta are powering the AI revolution
Kristie Batten: Sky’s the limit for Tallebung in hot tin market
Featured in Mining
Tech
ASX Tech October Winners: Sector buckles under Xero and WiseTech, but Weebit joins $1bn club
ASX Quarterly Tech Wrap: Acquisitions, deals and capital raises
The biometric edge: Can algorithms help you crack the three-hour marathon?
Air traffic bombarded by cyber criminals every day
Back Australia: We either innovate, or we will stagnate … it’s that simple
Featured in Tech
Health & Biotech
Biocurious: Buoyed by capital raisings, biotechs storm home with a wet sail
ASX Health October Winners: When CSL sneezes, sector catches flu
ASX Health Quarterly Wrap: Progress on multiple fronts in strong start to FY26
Health Check: Biotechs canter into November, but the ‘favourites’ have lead in their saddlebags
Dr Boreham’s Crucible: Nova Eye’s US vision sharpens as profits come into view
Featured in Health & Biotech
Experts
How the cheapest ETF investment strategy is minting millionaires
Reasons why inflation is high and an interest rate cut is off the table for the RBA
Stock Tips: Energy, property and F1-fuelled momentum drive this week’s picks
Criterion: In fostering truly sustainable investments, ELM waters the flowers and not the weeds
How to follow Rinehart’s lead and play the critical minerals boom
Clever or crazy? How to crack the airline status game with one flight
Is Jerome Powell’s likely rate cut pause a warning?
